ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 267 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,208,353 | -24.6% | 156,619 | +0.1% | 0.01% | -20.0% |
Q2 2023 | $5,578,829 | +67.3% | 156,445 | +19.1% | 0.02% | +50.0% |
Q1 2023 | $3,335,477 | -48.3% | 131,318 | -17.5% | 0.01% | -54.5% |
Q4 2022 | $6,456,138 | -42.3% | 159,175 | -53.0% | 0.02% | -38.9% |
Q3 2022 | $11,197,000 | -6.2% | 338,792 | -0.0% | 0.04% | -5.3% |
Q2 2022 | $11,934,000 | -70.9% | 338,942 | -62.0% | 0.04% | -62.4% |
Q1 2022 | $40,988,000 | -37.6% | 891,241 | -10.1% | 0.10% | -27.3% |
Q4 2021 | $65,729,000 | +4.5% | 991,393 | -1.6% | 0.14% | -2.1% |
Q3 2021 | $62,904,000 | -25.0% | 1,007,594 | -0.6% | 0.14% | -26.0% |
Q2 2021 | $83,911,000 | +36.9% | 1,013,173 | +9.6% | 0.19% | +27.2% |
Q1 2021 | $61,299,000 | +20.2% | 924,430 | +39.1% | 0.15% | +19.8% |
Q4 2020 | $50,998,000 | +218.9% | 664,637 | +78.9% | 0.13% | +157.1% |
Q3 2020 | $15,993,000 | +42.0% | 371,421 | +42.5% | 0.05% | +19.5% |
Q2 2020 | $11,260,000 | +255.0% | 260,709 | +136.5% | 0.04% | +156.2% |
Q1 2020 | $3,172,000 | -36.4% | 110,250 | +40.3% | 0.02% | -15.8% |
Q4 2019 | $4,985,000 | +6.4% | 78,594 | -52.7% | 0.02% | 0.0% |
Q3 2019 | $4,686,000 | +6.6% | 166,294 | +0.3% | 0.02% | +5.6% |
Q2 2019 | $4,394,000 | +42.9% | 165,794 | -1.0% | 0.02% | +38.5% |
Q1 2019 | $3,074,000 | +48.4% | 167,494 | +0.4% | 0.01% | +30.0% |
Q4 2018 | $2,072,000 | – | 166,847 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |